Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Authors: Nicola P. Klein, Melissa S. Stockwell, Maria Demarco, Manjusha Gaglani, Anupam B. Kharbanda, Stephanie A. Irving, Suchitra Rao, Shaun J. Grannis, Kristin Dascomb, Kempapura Murthy, Elizabeth A. Rowley, Alexandra F. Dalton, Malini B. DeSilva, Brian E. Dixon, Karthik Natarajan, Edward Stenehjem, Allison L. Naleway, Ned Lewis, Toan C. Ong, Palak Patel, Deepika Konatham, Peter J. Embi, Sarah E. Reese, Jungmi Han, Nancy Grisel, Kristin Goddard, Michelle A. Barron, Monica Dickerson, I-Chia Liao, William F. Fadel, Duck-Hye Yang, Julie Arndorfer, Bruce Fireman, Eric P. Griggs, Nimish R. Valvi, Carly Hallowell, Ousseny Zerbo, Sue Reynolds, Jill Ferdinands, Mehiret H. Wondimu, Jeremiah Williams, Catherine H. Bozio, Ruth Link-Gelles, Eduardo Azziz-Baumgartner, Stephanie J. Schrag, Mark G. Thompson, Jennifer R. Verani

Published: 2022-03-01

DOI: 10.15585/mmwr.mm7109e3

Source: Full article

---

Abstract

No abstract found.